X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-04 | SHC | Warburg Pincus & Co. | Dir, 10% | S - Sale | $14.31 | -16,594,363 | 88,822,952 | -16% | -$237,423,849 | ||||||
2024-03-04 | SHC | Warburg Pincus & Co. | Dir, 10% | S - Sale | $14.31 | -16,594,363 | 88,822,952 | -16% | -$237,423,849 | ||||||
2024-03-04 | SHC | Gtcr Investment Xi LLC | Dir, 10% | S - Sale | $14.31 | -11,062,908 | 59,215,301 | -16% | -$158,282,556 | ||||||
2024-03-04 | SHC | Klee Ann R. | Dir | S - Sale | $14.31 | -5,750 | 86,735 | -6% | -$82,268 | ||||||
| D | 2024-03-04 | SHC | Rutz Michael P | Pres of Sterigenics | S - Sale+OE | $14.31 | -83,109 | 544,409 | -13% | -$1,189,082 | |||||
| D | 2024-03-04 | SHC | Petras Michael B. Jr. | COB, CEO | S - Sale+OE | $14.31 | -1,003,870 | 6,153,329 | -14% | -$14,362,870 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |